Effects of Glucagon like Peptide-1 agonists on patients with overactive bladder: A pilot study

Purpose:: To explore preliminary data on the subjective impact of Glucagon-Like Peptide-1 (GLP-1) agonists, commonly used for diabetes and obesity, on symptoms of overactive bladder (OAB), in order to guide future, larger-scale investigations. Methods:: We distributed an anonymous survey on an onlin...

Full description

Saved in:
Bibliographic Details
Main Authors: Max D. Sandler, Adam D. Williams, Alan Wein, Katherine Amin, Raveen Syan
Format: Article
Language:English
Published: Elsevier 2025-06-01
Series:Continence Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2772974525000067
Tags: Add Tag
No Tags, Be the first to tag this record!